1. Home
  2. VTEX vs EOLS Comparison

VTEX vs EOLS Comparison

Compare VTEX & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTEX
  • EOLS
  • Stock Information
  • Founded
  • VTEX 1999
  • EOLS 2012
  • Country
  • VTEX Cayman Islands
  • EOLS United States
  • Employees
  • VTEX N/A
  • EOLS N/A
  • Industry
  • VTEX Computer Software: Prepackaged Software
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTEX Technology
  • EOLS Health Care
  • Exchange
  • VTEX Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • VTEX 863.0M
  • EOLS 854.0M
  • IPO Year
  • VTEX 2021
  • EOLS 2018
  • Fundamental
  • Price
  • VTEX $5.06
  • EOLS $11.78
  • Analyst Decision
  • VTEX Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • VTEX 2
  • EOLS 4
  • Target Price
  • VTEX $10.00
  • EOLS $24.67
  • AVG Volume (30 Days)
  • VTEX 880.0K
  • EOLS 748.3K
  • Earning Date
  • VTEX 05-06-2025
  • EOLS 03-04-2025
  • Dividend Yield
  • VTEX N/A
  • EOLS N/A
  • EPS Growth
  • VTEX N/A
  • EOLS N/A
  • EPS
  • VTEX 0.06
  • EOLS N/A
  • Revenue
  • VTEX $226,709,000.00
  • EOLS $266,274,000.00
  • Revenue This Year
  • VTEX $17.22
  • EOLS $34.56
  • Revenue Next Year
  • VTEX $18.43
  • EOLS $32.26
  • P/E Ratio
  • VTEX $82.26
  • EOLS N/A
  • Revenue Growth
  • VTEX 12.50
  • EOLS 31.76
  • 52 Week Low
  • VTEX $4.20
  • EOLS $9.25
  • 52 Week High
  • VTEX $9.10
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • VTEX 49.62
  • EOLS 35.35
  • Support Level
  • VTEX $4.81
  • EOLS $13.07
  • Resistance Level
  • VTEX $5.26
  • EOLS $13.66
  • Average True Range (ATR)
  • VTEX 0.21
  • EOLS 0.58
  • MACD
  • VTEX 0.10
  • EOLS -0.15
  • Stochastic Oscillator
  • VTEX 81.97
  • EOLS 22.22

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: